Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength.

Cited by (280)

Items 101–200 of 280

1. Alendronate and raloxifene affect the osteoprotegerin/RANKL system in human osteoblast primary cultures from patients with osteoporosis and osteoarthritis
   Mercè Giner, Ma José Rios, Ma José Montoya, María Ángeles Vázquez, Cristina Miranda, Ramón Pérez‐Cano · 2010 · European Journal of Pharmacology
2. Therapeutic approaches to myeloma bone disease: An evolving story
   Vito Longo, Oronzo Brunetti, Stella D’Oronzo, Franco Dammacco, Franco Silvestris · 2012 · Cancer Treatment Reviews
3. Assessment of Denosumab in Korean Postmenopausal Women with Osteoporosis: Randomized, Double-Blind, Placebo-Controlled Trial with Open-Label Extension
   Jung‐Min Koh, Dong Jin Chung, Yoon‐Sok Chung, Moo-Il Kang, In-Ju Kim, Yong‐Ki Min, Han Jin Oh, Il Hyung Park, Yil-Seob Lee, Barbara G. Kravitz et al. · 2016 · Yonsei Medical Journal
4. Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand
   Qing-Ping Wang, Li Yang, Xianping Li, Hui Xie, Er-Yuan Liao, Min Wang, Xiang‐Hang Luo · 2012 · Bone
5. Aromatase Inhibitor-Associated Bone Loss
   Shubham Pant, Charles L. Shapiro · 2008 · Drugs
6. Effect of denosumab, a human monoclonal antibody of receptor activator of nuclear factor kappa-B ligand (RANKL), upon glycemic and metabolic parameters
   Ichiro Abe, Kentaro Ochi, Yuichi Takashi, Yuka Yamao, Hanako Ohishi, Hideyuki Fujii, Midori Minezaki, Kaoru Sugimoto, Tadachika Kudo, Makiko Abe et al. · 2019 · Medicine
7. Osteoclastic activity was associated with the development of steroid-induced osteonecrosis of femoral head
   Mincong He, Jin Zhang, Xiaojun Chen, Ying-Shan Shen, Bin Fang, Yi‐Xian Qin, Wei He, Qiushi Wei · 2020 · Artificial Cells Nanomedicine and Biotechnology
8. The role and efficacy of denosumab in the treatment of osteoporosis: an update
   Ioannis Charopoulos, Steve M. Orme, Peter Vasilios Giannoudis · 2011 · Expert Opinion on Drug Safety
9. Conditional expression of constitutively active estrogen receptor α in osteoblasts increases bone mineral density in mice
   Kazuhiro Ikeda, Tohru Tsukui, Kuniko Horie‐Inoue, Satoshi Inoue · 2011 · FEBS Letters
10. Progress and Outlook of Inorganic Nanoparticles for Delivery of Nucleic Acid Sequences Related to Orthopedic Pathologies: A Review
    Darcy Elizabeth Wagner, Sarit B. Bhaduri · 2011 · Tissue Engineering Part B Reviews
11. RANK, RANKL and OPG Expression in Breast Cancer – Influence on Osseous Metastasis
    Jasmin Teresa Ney, Tanja Natascha Fehm, Ingolf Juhasz-Böess, Erich‐Franz Solomayer · 2012 · Geburtshilfe und Frauenheilkunde
12. Targeting cancer metastasis with antibody therapeutics
    Yang Hui-lin, Yun‐Huai Kuo, Zion Smith, Jamie B. Spangler · 2021 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
13. The Short-Term Effect of Prunes in Improving Bone in Men
    Kelli S. George, Joseph Muñoz, Lauren T. Ormsbee, Neda Sara Akhavan, Elizabeth Foley, Shalom C. Siebert, Jeong‐Su Kim, Robert Charles Hickner, Bahram Herman Arjmandi · 2022 · Nutrients
14. OPG/RANKL
    Pierre J. Marie, Philippe Halbout · 2008 · médecine/sciences
15. Relationship between osteoprotegerin and mortality in decompensated heart failure with preserved ejection fraction
    Óscar Aramburu‐Bodas, Beatriz García-Casado, Prado Salamanca‐Bautista, María Esther Guisado Espartero, José Luis Arias‐Jiménez, Antonio Barco-Sánchez, Juan Carlos Santamaría-González, Francesç Formiga, Manuel Montero-Pérez-Barquero, Luís Manzano · 2014 · Journal of Cardiovascular Medicine
16. The Basics and Science of Tendon Transfers
    Eric Michael Bluman, Thomas C. Dowd · 2011 · Foot and Ankle Clinics
17. Age-associated (cardio)metabolic diseases and cross-talk between adipose tissue and skeleton: endocrine aspects
    Silvia Migliaccio, Emanuela Alessandra Greco, Antônio Aversa, Andrea Lenzi · 2014 · Hormone Molecular Biology and Clinical Investigation
18. Meta-analysis of the effects of denosumab and romosozumab on bone mineral density and turnover markers in patients with osteoporosis
    Mingwei Hu, Yifan Zhang, Jianjun Guo, Cuicui Guo, Xue Yang, Xue Ma, Hao Xu, Shuai Xiang · 2023 · Frontiers in Endocrinology
19. Temporal and spatial expression of osteoprotegerin and receptor activator of nuclear factor -κB ligand during mandibular distraction in rats
    Wei-qiao Zhu, Xing Wang, Xiaoxia Wang, Zhiying Wang · 2007 · Journal of Cranio-Maxillofacial Surgery
20. Alginate Oligosaccharide and Gut Microbiota: Exploring the Key to Health
    Meiling Song, Lin Chen, Dong Chen, Minghui Tang, Yuan Wei, Depeng Lv, Quancai Li, Zhen Chen · 2025 · Nutrients
21. Denosumab improves glucose parameters in patients with impaired glucose tolerance: a systematic review and meta-analysis
    Blanca T. Pacheco-Soto, Rebeca Garazi Elguezabal-Rodelo, Leonardo M. Porchia, Enrique Torres‐Rasgado, Ricardo Pérez-Fuentes, M. Elba González-Mejía · 2021 · Journal of Drug Assessment
22. Stabilization of tooth movement by administration of reveromycin A to osteoprotegerin-deficient knockout mice
    Takahiro Yabumoto, Ken Miyazawa, Masako Tabuchi, Satsuki Shoji, Miyuki Tanaka, Manami Kadota, Mamoru Yoshizako, Makoto Kawatani, Hiroyuki Osada, Hatsuhiko Maeda et al. · 2013 · American Journal of Orthodontics and Dentofacial Orthopedics
23. RANKL and OPG expression: Jiggling force affects root resorption in rats
    Yayoi Matsuda, Masahide Motokawa, Masato Kaku, Hiromi Sumi, Kazuo Tanne, Kotaro Tanimoto · 2016 · The Angle Orthodontist
24. Recent Advances in Orthodontic Retention Methods: A Review article
    Ahmad Jobran H Swidi, Reginald W. Taylor, Larry P. Tadlock, Peter H. Buschang · 2018 · Journal of the World Federation of Orthodontists
25. Osteoprotegerin: A novel biomarker for inflammatory bowel disease and gastrointestinal carcinoma
    Floris A. E. de Voogd, Richard Blair Gearry, Christopher J. Mulder, Andrew Stewart Day · 2016 · Journal of Gastroenterology and Hepatology
26. Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis
    Rouven Schoenhof, Adelheid Munz, Anna Yuan, Ashraf ElAyouti, Hans C. Bösmüller, Gunnar Blumenstock, Siegmar Reinert, Sebastian Hoefert · 2021 · Journal of Cranio-Maxillofacial Surgery
27. Models and screening assays for drug discovery in osteoporosis
    Jukka P. Rissanen, Jussi M. Halleen · 2010 · Expert Opinion on Drug Discovery
28. Associations of Bone Mineral Density with RANKL and Osteoprotegerin in Arab Postmenopausal Women: A Cross-Sectional Study
    Osama Emam Amer, Kaiser Wani, Mohammed Ghouse Ahmed Ansari, Abdullah M. Alnaami, Naji Aljohani, Saba Abdi, Syed Danish Hussain, Nasser M. Al‐Daghri, Majed Saleh Alokail · 2022 · Medicina
29. Could medications and biologic factors affect post‐orthodontic tooth movement changes? A systematic review of animal studies
    Eleftherios G. Kaklamanos, Miltiadis A. Makrygiannakis, Athanasios E. Athanasiou · 2020 · Orthodontics and Craniofacial Research
30. Modulatory effects of l-arginine and soy enriched diet on bone homeostasis abnormalities in streptozotocin-induced diabetic rats
    Shohda A. El‐Maraghy, Noha A. Mehana · 2015 · Chemico-Biological Interactions
31. A comparatively study of menaquinone-7 isolated from Cheonggukjang with vitamin K1 and menaquinone-4 on osteoblastic cells differentiation and mineralization
    Weijie Wu, Haiyan Gao, Jong‐Sik Jin, Byung-Yong Ahn · 2019 · Food and Chemical Toxicology
32. Baicalin inhibits root resorption during tooth movement in a rodent model
    Ryo Kunimatsu, Aya Kimura, Yuji Tsuka, Kayo Horie, Yuki Yoshimi, Tetsuya Awada, Hidemi Gunji, Takaharu Abe, Kengo Nakajima, Sakata Syuzou et al. · 2020 · Archives of Oral Biology
33. A randomized placebo-controlled trial of the efficacy of denosumab in Indian postmenopausal women with osteoporosis
    Barbara G. Kravitz, Shailesh Pitale, Mathew Thomas, Gaurav Rathi, Vaishali Chetan Deshmukh, Prasanna K. M. Kumar, Sanjay C Reddy, Naresh Shetty, Atul Kakar, Sushrut Babhulkar et al. · 2014 · Indian Journal of Endocrinology and Metabolism
34. The effect of supplementation of a glutamine precursor on the growth plate, articular cartilage and cancellous bone in fundectomy-induced osteopenic bone
    Ewa Tomaszewska, Piotr Dobrowolski, Łukasz Prost, Monika Hułas‐Stasiak, Siemowit Muszyński, Tomasz Blicharski · 2015 · Journal of Veterinary Medical Science
35. Establishment and validation of an in vitro co-culture model for oral cell lines using human PBMC-derived osteoclasts, osteoblasts, fibroblasts and keratinocytes
    Daniel Steller, Alexandra Scheibert, Tabea Sturmheit, Samer George Hakim · 2020 · Scientific Reports
36. Integrated computational and in vivo models reveal Key Insights into macrophage behavior during bone healing
    Etienne Baratchart, Chen Hao Lo, Conor C. Lynch, David Basanta · 2022 · PLoS Computational Biology
37. Knochenstoffwechsel
    Elena Neumann, Georg Andreas Schett · 2007 · Zeitschrift für Rheumatologie
38. Odanacatib increases mineralized callus during fracture healing in a rabbit ulnar osteotomy model
    Brenda L Pennypacker, David B. Gilberto, Nicholas T. Gatto, Rana Samadfam, Susan Y. Smith, Donald B. Kimmel, Le T. Duong · 2015 · Journal of Orthopaedic Research®
39. Targeting Drug Delivery in the Elderly: Are Nanoparticles an Option for Treating Osteoporosis?
    Gudrun C. Thurner, Johannes Haybaeck, Paul L. Debbage · 2021 · International Journal of Molecular Sciences
40. Effects of Drugs and Chemotherapeutic Agents on Dental Implant Osseointegration: A Narrative Review
    Aida Mohammadi, Nazanin Roqani Dehkordi, Sadaf Mahmoudi, Niyousha Rafeie, Hamoun Sabri, Maryam Valizadeh, Taniya Poorsoleiman, Aryan Jafari, Alireza Mokhtari, Arshia Khanjarani et al. · 2022 · Current Clinical Pharmacology
41. The Dissection of Human Autosomal Recessive Osteopetrosis Identifies an Osteoclast-Poor Form Due to RANKL Deficiency
    Annalisa Frattini, Paolo Vezzoni, ANNA MARIA VILLA, Cristina Sobacchi · 2007 · Cell Cycle
42. Pathophysiology and Therapeutic Management of Bone Loss in Patients with Critical Illness
    Tae Jin Kim, Hyojin Kim · 2023 · Pharmaceuticals
43. Effect of L-Carnitine Supplementation on Secondary Hyperparathyroidism and Bone Metabolism in Hemodialyzed Patients
    Roman Cibulka, Jaroslav Ráček, Richard Pikner, Daniel Rajdl, Ladislav Trefil, Eugenie Vesela, M Studenovská, Romana Siroka · 2007 · Calcified Tissue International
44. Denosumab in postmenopausal osteoporosis: what the clinician needs to know
    Edward Michael Lewiecki · 2009 · Therapeutic Advances in Musculoskeletal Disease
45. Conjugated linoleic acid and glucosamine supplements may prevent bone loss in aging by regulating the RANKL/RANK/OPG pathway
    Shaymaa J. Abdulrahman, Mohanad Ali Abdulhadi, Abduladheem Turki Jalil, Dumooa Falah, Muna Salih Merza, Abbas Firras Almulla, Ahmed Ali, Ronak Taher Ali · 2023 · Molecular Biology Reports
46. Expression of osteoprotegerin, RNAK and RANKL genes in femoral head avascular necrosis and related signaling pathway.
    Qingtang Miao, Sibin Hao, Hongmei Li, Fang Sun, Xueling Wang · 2015 · PubMed Central
47. Denosumab: A Promising Drug for the Prevention and Treatment of Osteoporosis
    Edward Michael Lewiecki · 2006 · Women s Health
48. Endocrine Therapy and Bone Loss in Breast Cancer: Time to Close in the RANK(L)?
    Per Eystein Lønning · 2008 · Journal of Clinical Oncology
49. Severe hypocalcemia after denosumab in a patient with acquired Fanconi syndrome
    Hammad Shafqat, Kawther F. Alquadan, Adam J. Olszewski · 2013 · Osteoporosis International
50. Effects of osteoprotegerin, RANK and RANKL on bone destruction and collapse in avascular necrosis femoral head.
    Mingyue Xiong, Li-Qiang Liu, Shi-Qiong Liu, Zhenhui Liu, Hangfei Gao · 2016 · Europe PMC (PubMed Central)
51. Osteoprotegerin Plasma Levels are Strongly Associated with Polymorphisms in Human Homologue of the Mouse Progressive Ankylosis (ANKH) Gene
    Yulia Vistoropsky, Ida Malkin, Eugene Kobyliansky, Gregory Livshits · 2006 · Annals of Human Genetics
52. Gelatin Porous Scaffolds as Delivery Systems of Calcium Alendronate
    Silvia Panzavolta, Paola Torricelli, Sonia Casolari, Annapaola Parrilli, Sofia Amadori, Milena Fini, Adriana Bigi · 2016 · Macromolecular Bioscience
53. Denosumab might prevent periprosthetic bone loss after total hip and knee arthroplasties: a review
    Jianda Xu, Huan Li, Yuxing Qu, Chong Ren Zheng, Bin Wang, Pengfei Shen, Zikang Xie, Kang Wei, Yan Wang, Jianning Zhao · 2021 · Arthroplasty
54. Identification of drug candidate for osteoporosis by computational bioinformatics analysis of gene expression profile
    Guiyong Yu, Litao Wang, Yazhou Li, Zhihong Ma, Yu Li · 2013 · European journal of medical research
55. Osteoimmunological Aspects on Inflammation and Bone Metabolism
    U. Lange, G. Dischereit, E. Neumann, K. Frommer, I. Tarner, Müller-Ladner Kerckhoff-Klinik · 2015 · Journal of Rheumatic Diseases and Treatment
56. Effect of parathyroidectomy on osteopontin and undercarboxylated osteocalcin in patients with primary hyperparathyroidism
    Raelene E. Maser, M. James Lenhard, Ryan Todd Pohlig, Prabhakaran Balagopal, Raafat Abdel‐Misih · 2017 · Endocrine Research
57. Hypergravity Provokes a Temporary Reduction in CD4+CD8+ Thymocyte Number and a Persistent Decrease in Medullary Thymic Epithelial Cell Frequency in Mice
    Ryosuke Tateishi, Nobuko Akiyama, Maki Miyauchi, Yoshinaga Riko, Hiroki Sasanuma, Takashi Kudo, Miki Shimbo, Masahiro Shinohara, Koji Obata, Jun‐ichiro Inoue et al. · 2015 · PLoS ONE
58. Microarray analysis of Leflunomide-induced limb malformations in CD-1 mice
    Ryou Fukushima, Masako Kaneto, Hiroshi Kitagawa · 2009 · Reproductive Toxicology
59. Changes in mRNA gene expression during growth in the femoral head of the young rat
    Ralph A. Meyer, Martha H. Meyer, Nomaan Ashraf, Steven L. Frick · 2007 · Bone
60. RANK/RANKL Signaling Pathway in Breast Development and Cancer
    Gema Pérez-Chacón, Patricia G. Santamarı́a, Jaime Redondo-Pedraza, Eva González‐Suárez · 2025 · Advances in experimental medicine and biology
61. Expert opinion 2011 on the use of new anti-resorptive agents in the prevention of skeletal-related events in metastatic bone disease
    Rodica Maricela Anghel, Alexander Bachmann, Meral Beksaç, Thomas Brodowicz, Jindřich Fínek, Radko Komadina, Krzysztof Krzemieniecki, István Láng, Jozef Marenčák, Roger von Moos et al. · 2013 · Wiener klinische Wochenschrift
62. Future Developments in Osteoporosis Therapy
    K.W. Ng · 2009 · Endocrine Metabolic & Immune Disorders - Drug Targets
63. Denosumab (AMG 162), a Fully Human Monoclonal Antibody Against RANK Ligand Activity
    G. Kesava Reddy, Eric Nadler, Vinay Kumar Jain · 2005 · Supportive Cancer Therapy
64. Novel Approaches in the Management of Myeloma-Related Skeletal Complications
    G. Kesava Reddy, Tariq I. Mughal, G. David Roodman · 2006 · Supportive Cancer Therapy
65. Role of denosumab in breast cancer
    Rupert Bartsch, Guenther G. Steger · 2009 · Expert Opinion on Biological Therapy
66. Role of Masticatory Force in Modulating Jawbone Immunity and Bone Homeostasis: A Review
    Yue Song, Jiao Yao, Yitong Liu, Lijia Guo · 2025 · International Journal of Molecular Sciences
67. Enzyme-responsive liposomes target endoplasmic reticulum stress-mediated apoptosis for rheumatoid arthritis therapy
    Chenglong Li, Can Qian, Jie Zhang, Ya Huang, Xiaolin Zhao, Huaiyu Su, Yingying Hou, C Li · 2025 · Phytomedicine
68. FXR in bone metabolism: An emerging regulator
    S M Mahamudul Hassan Rizvi, Shami· Aihemaiti, Yun Kan, Shengxiang Tao, Hui Liu · 2026 · iScience
69. Cellular signatures in human blood track bone mineral density in postmenopausal women
    Kaichi Kaneko, Jefferson Tsai, Deniece Meñez, Brian Oh, Andrew J. Suh, Seyeon Bae, Masataka Mizuno, Akio Umemoto, Ευγενία Γιαννοπούλου, Takayuki Fujii et al. · 2024 · JCI Insight
70. Genetic analysis of serum osteocalcin and bone mineral in multigenerational Afro-Caribbean families
    Allison L. Kuipers, Caren M. Gundberg, Candace M. Kammerer, Amy Dressen, Cara S. Nestlerode, A. L. Patrick, Victor W. Wheeler, Clareann H. Bunker, Anne B. Newman, Joseph M. Zmuda · 2011 · Osteoporosis International
71. The relation between the RANKL and resistin in menopausal women with osteoporosis
    Rusul Ali Al-Masaoodi, Alaauldeen S. M. AL-Sallami, Hamadalla Hadi Al-Baseesee · 2019 · AIP conference proceedings
72. [Progress of research on the relationship between calcitonin gene-related peptide and RANK/RANKL/OPG system in the bone reconstruction].
    Shiyao Wang, Shaoce Xu, Zhengwei Shi, Jian-Chao Wu, Shuanhu Lei, Yuliang Wang · 2019 · Europe PMC (PubMed Central)
73. Differential Osteoprotegerin Kinetics after Stimulation with Desmopressin and Lipopolysaccharides In Vivo
    Nina Buchtele, Katarina D. Kovacevic, Christine Brostjan, Michael Schwameis, Hubert Hayden, Ulla Derhaschnig, Christa Firbas, Bernd Jilma, Christian Schoergenhofer · 2020 · Thrombosis and Haemostasis
74. Biological Markers in the Gingival Crevicular Fluid Associated with External Invasive Resorption: A Split-Mouth Cross-Sectional Study
    Matthew Malek, Laura Steff, Nikita Vakil, Rathimala Jothilingam, Sunna Huh, Tiffany Chien, Rachel Halpern, Nihan Gencerliler, Özge Erdoğan, Kamolthip Songtrakul · 2024 · Journal of Endodontics
75. Effect of compressive loading and incubation with clodronate on the RANKL/OPG system of human osteoblasts
    Sarah Grimm, Christian Walter, Andreas Max Pabst, Jutta Goldschmitt, Heiner Wehrbein, Collin Jacobs · 2015 · Journal of Orofacial Orthopedics / Fortschritte der Kieferorthopädie
76. Increased serum osteoprotegerin in patients with primary adrenal insufficiency receiving conventional hydrocortisone substitution.
    Marta Fichna, Magdalena Żurawek, Piotr Fichna, Maria Gryczyńska, J Nowak, Marek Ruchała · 2012 · PubMed
77. Cardiovascular benefits and risks associated with calcium, vitamin D, and antiresorptive therapy in the management of skeletal fragility
    Annop Kittithaworn, David Toro-Tobón, Jad G. Sfeir · 2023 · Women s Health
78. Osteonecrosis de los maxilares asociada a denosumab en una paciente con osteoporosis: un caso clínico
    Blas García García, Alicia Dean Ferrer, Nélida Díaz Jiménez, F.J. Alamillos Granados · 2014 · Revista Española de Cirugía Oral y Maxilofacial
79. Does denosumab improve low BMD in postmenopausal women?
    Murray J. Favus · 2006 · Nature Clinical Practice Endocrinology & Metabolism
80. Roles of SP600125 in expression of JNK, RANKL and OPG in cultured dental follicle cells
    Qi Wang, Xiaojuan Yuan, Boqi Li, Dalei Sun, Jia Liu, Tao Liu, Xiaojuan Bi, Yishan Liu · 2019 · Molecular Biology Reports
81. Dual effects of bisphosphonates on bone metabolism and implant osseointegration: mechanisms, risks and clinical strategies
    Hongqi Liu, Xinjing Wang, Yueyi Shi, Yanmei Yang, Pengli Li, Qi Chen, Yawen Hu, Jian Wang, Bin Gu · 2025 · Journal of Stomatology Oral and Maxillofacial Surgery
82. Local delivery of osteoprotegerin may be a way of reinforcing orthodontic anchorage
    Yongming Li, Lin Tang · 2008 · Medical Hypotheses
83. Effect of escitalopram and carbidopa on bone markers in Wistar rats: a preliminary experimental study
    Ravisha Wadhwa, Manoj Kumar, Yam Nath Paudel, Ramsha Iqbal, Priyanka Kothari, Ritu Trivedi, Divya Vohora · 2018 · Journal of Bone and Mineral Metabolism
84. Rheuma und Knochenstoffwechsel
    Gabriel Dischereit, Uwe Lange · 2019 · Der Orthopäde
85. Effects of anti-mouse RANKL antibody on orthodontic tooth movement in mice
    Masako Yoshimatsu, Hideki Kitaura, Yukiko Morita, Takuya Nakamura, Takashi Ukai · 2022 · Journal of Dental Sciences
86. Bone metabolism and RANKL/RANK/OPG trail in periodontal disease
    Łukasz Czupkałło, Mansur Rahnama, Dominik Kielbowicz, Michał Łobacz, Maryla Kozicka-Czupkałło · 2016 · Current Issues in Pharmacy and Medical Sciences
87. New agents for the treatment of osteoporosis
    Thomas John Martin, Kong Wah Ng · 2007 · BoneKEy-Osteovision
88. Targeting BMP2 signaling pathway in osteogenesis and osteoarthritis: A path toward safer regenerative therapies
    Newton Suwal, Saurav Kumar Jha, Rajan Thapa, Saroj Bashyal, Sudarshan Poudel, Sefina Gwachha, Laxmi Akhileshwar Jha, Nisha Panth, Sobia Idrees, Gaurav Gupta et al. · 2026 · Cellular Signalling
89. Regulación del metabolismo óseo a través del sistema RANK-RANKL-OPG
    Neyro Bilbao Jl, Ariel Sánchez, Santiago Palacios Gil‐Antuñano · 2011 · DOAJ (DOAJ: Directory of Open Access Journals)
90. Gene network analysis to determine the effect of hypoxia-associated genes on brain damages and tumorigenesis using an avian model
    Hamed Kharrati-Koopaee, Esmaeil Ebrahimie, Mohammad Dadpasand, Ali Niazi‎, Rugang Tian, Ali Esmailizadeh · 2021 · Journal of Genetic Engineering and Biotechnology
91. VDR, RANKL and OPG polymorphisms as possible predisposing cofactors of postmenopausal osteoporosis: explorative study in Italian population
    Elisabetta Mamolini, Carlo Cervellati, Pantaleo Greco, Alberto Carrieri, Leo Massari, Ilaria Crivellari, Chiara Scapoli, Gloria Bonaccorsi · 2017 · Gynecological Endocrinology
92. A Crucial Role of IL-17 in Bone Resorption During Rejection of Fresh Bone Xenotransplantation in Rats
    Jiabing Sun, Xuming Wang, Chunjiang Fu, Dewei Wang, Zhenggang Bi · 2014 · Cell Biochemistry and Biophysics
93. VERTEBRAL OSTEOMYELITIS IS CHARACTERISED BY INCREASED RANK/OPG AND RANKL/OPG EXPRESSION RATIOS IN VERTEBRAL BODIES AND INTERVERTEBRAL DISCS
    Siegmund Lang, Markus Loibl, Joachim Gläsner, M Simon, Markus Rupp, Sibylle Grad, Carsten Neumann, Volker Alt, André Gessner, Frank Hanses · 2021 · University of Regensburg Publication Server (University of Regensburg)
94. Evaluating the Effect of Denosumab in Preventing Anchorage Loss: A Split-mouth Randomized Controlled Trial
    Shankargouda Patil, Shankargouda Patil, Arvind Sivakumar, SP Saravana Dinesh, Abdulrahman Saleh Alshehri, Wael Awadh · 2022 · The Journal of Contemporary Dental Practice
95. The skeleton: an overlooked regulator of systemic glucose metabolism in cancer?
    Rucha Ronghe, Adriana Tavares · 2024 · Frontiers in Oncology
96. Recreational Exercise and Inflammatory Patterns in Hashimoto’s Thyroiditis: Observations from a Cross-Sectional Study
    Marko Vuletić, Vanna Žnidar, Ana Barić Žižić, Sanda Sladić, Dean Kaličanin, Vesela Torlak Lovrić, Maja Cvek, Ante Punda, Vesna Boraska Perica · 2025 · Biomolecules
97. Estrogen deficiency and bone loss in women with breast cancer
    Charles L. Shapiro · 2010 · Breast Cancer Research and Treatment
98. Immunohistochemical analysis of osteoclastic and osteoblastic activity in ossifying fibroma and juvenile ossifying fibroma: A comparative study
    Jawaher M. Tater, Ameena Ryhan Diajil · 2023 · Journal of Medicine and Life
99. Exploring the Logic and Conducting a Comprehensive Evaluation of the Adiponectin Receptor Agonists AdipoRon and AdipoAI’s Impacts on Bone Metabolism and Repair-A Systematic Review
    Lucas Fornari Laurindo, Giulia Minniti, Victória Dogani Rodrigues, Lívia Fornari Laurindo, Virgínia Maria Cavallari Strozze Catharin, Eduardo Federighi Baisi Chagas, Vinícius Dias dos Anjos, Marcela Vialogo Marques de Castro, Edgar Baldi, Raquel Cristina Ferraroni Sanches et al. · 2024 · Current Medicinal Chemistry
100. The Charcot Foot Revisited: How the New Pathogenetic Findings Explain the Clinical Course of the Disease
     Nina L. Petrova · 2017 · Frontiers in diabetes